期刊文献+

免疫抑制剂不合理用药典型案例解析 被引量:2

Analysis of typical cases of irrational use of immunosuppressants
下载PDF
导出
摘要 目的:通过对门诊处方和住院医嘱审核中发现的免疫抑制剂不合理使用典型案例进行解析,提高医院合理用药水平。方法:通过查阅药品说明书、相关的指南及文献,对门诊处方及住院医嘱审核中发现的免疫抑制剂不合理使用典型案例进行详细的解析。结果:免疫抑制剂门诊处方和住院医嘱审核中发现的主要问题是钙调磷酸酶抑制剂与他汀类药物、大环内酯类抗菌药物、质子泵抑制剂、利福平、五酯胶囊以及唑类抗真菌药物等之间的药物相互作用问题。结论:免疫抑制剂中的钙调磷酸酶抑制剂与多种药物之间存在有临床意义的相互作用,是免疫抑制剂不合理处方的常见问题,应该作为药师审核处方(医嘱)时的关注重点。 Objective:To analyze the typical cases of irrational use of immunosuppressants in the review of outpatient prescriptions and inpatient medical orders,so as to improve rational use of drugs in the hospital.Methods:By referring to drug instructions,relevant guidelines and literature,typical cases found in outpatient prescriptions and inpatient medical orders concerning irrational use of immunosuppressants were analyzed in detail.Results:The main problems identified in the review of outpatient prescriptions and inpatient medical orders of immunosuppressant drugs were the interactions between calcineurin inhibitors and statins,macrolide antibacterials,proton pump inhibitors,rifampin,Wuzhi capsules and azole antifungal agents.Conclusion:The clinical interactions between calcineurin inhibitors and a variety of drugs are common problems in irrational prescription of immunosuppressants and should be the focus of pharmacists when they review prescriptions and medical orders.
作者 陈泉金 沈钦勇 倪政彪 宋洪涛 CHEN Quanjin;SHEN Qinyong;NI Zhengbiao;SONG Hongtao(Department of Pharmacy,Fuzhou Second Hospital Affiliated to Xiamen University,Fuzhou 350007,China;No.900 Hospital of Joint Logistics Support Force,Fuzhou 350025,China)
出处 《药学服务与研究》 CAS 2020年第6期446-450,共5页 Pharmaceutical Care and Research
关键词 免疫抑制剂 处方审核 钙调磷酸酶抑制剂 药物相互作用 immunosuppressant prescription review calcineurin inhibitor drug interaction
  • 相关文献

参考文献5

二级参考文献42

  • 1闫春兰,詹金彪,陈枢青.浙江省汉族与畲族CYP2C19基因多态性研究[J].中国药学杂志,2004,39(11):866-868. 被引量:13
  • 2周健,吕虹,康熙雄.中国汉族人群不同性别、年龄、体重指数之间细胞色素氧化酶CYP2C19基因多态性的检测[J].中国临床药理学与治疗学,2007,12(2):208-213. 被引量:84
  • 3Van de Putte LB,De la Riviere GB,Van Breda Vriesman PJ,et al.Recurrent or persistent hematuria.Sign of mesangial immune-complex deposition[J].N Eng I J Med,1974,290(21):1165-1170.
  • 4Bhasin HK,Abuelo JG,Nayak R,et al.Mesangial proliferative Glomerulone-phritis[J].Lab Invest,1978,39(1):21-29.
  • 5Cohen AH,Border WA,Glassock RJ.Nephrotic syndrome with glomerular mesangial Ig M deposits[J].Lab Invest,1978,38(5):610-619.
  • 6Zhang JH,Li LS.Mesangial Ig M nephropathy[J].Zhonghua Nei Ke Za Zhi,1984,23(3):141-144.
  • 7Mubarak M.Ig M nephropathy;time to act[J].J Nephropathol,2014,3(1):22-25.
  • 8Mubarak M,Nasri H.Ig M nephropathy:timely response to a call for action[J].J Renal Inj Prev,2013,3(1):5-6.
  • 9Kazi J,Mubarak M.Ig M nephropathy presenting as full blown crescentic glomerulonephritis:first report in the literature[J].Nefrologia,2014,34(3):423-424.
  • 10Sumethkul V,Sakulsaengoraph A,Chalermsanyakorn P,et al.Survival analysis of the patients with Ig M nephropathy focal segmental glomerulosclerosis and membranous syndrome[J].J Med Assoc Thai,2000,83(1):S123-S129.

共引文献434

同被引文献32

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部